Peer Review History
| Original SubmissionJune 12, 2025 |
|---|
|
Dear Dr. Palkovics, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Adedapo Olutola Adediji, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “HUN-REN Hungarian Research Network (project number: 3200107). JA’s research was partly funded by the North American Lily Society Research Trust Fund Grant (grant number: 2024-02).” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 4. Please amend your authorship list in your manuscript file to include author László Palkovics. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments (if provided): The paper describes the occurrence of potyvirus in asymptomatic Galanthus nivalis. However, the reviewers provided critical and very sacrosanct grounds for the paper to be rewritten and additional data provided. I will recommend a major revision. In addition, there are major grammatical improvements to be made to the paper. In addition, there is a high similarity match with a paper previously published by the authors: this must be corrected before any consideration is given to publish or not. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The manuscript “Recombinant Potyvirus lilimaculae in asymptomatic Galanthus nivalis: Ecological and evolutionary implications” presents the results of viruses survey in asymptomatic snowdrops plants mainly from wild protected areas of Hungary. The authors found a virus species already described in other hosts, the lily mottle virus (Potyvirus lilimaculae). They also performed molecular phylogenetic studies based on CP nucleotide sequences and recombination analysis based on partial NIb and CP nucleotide sequences. The research was well conducted and results are important in relation to biodiversity aspect, although some aspects from the agronomic perspective could be better explored. I feel the conclusions by authors sometimes were overstated, mainly because the study was conducted with partial sequences. I also suggest the authors to conduct a phylogenetic analysis with predicted CP amino acids sequences. Some tables and figures can be moved to supplementary file, since are not essential for understanding by readers (I commented in the attached file). Other specific comments and suggestions are pointed out in the attached file. The manuscipt needs an english language revision. Reviewer #2: I have critically reviewed the manuscript title “Recombinant Potyvirus lilimaculae in asymptomatic Galanthus nivalis: Ecological and evolutionary implications”, which describes the asymptomatic infection of recombinant isolates of Lily mottle virus in Galanthus species. The authors used serological as well as molecular approaches for the detection of potyvirus group. There used mechanical inoculation method and found positive infection in the inoculated plants during the following year. Recombination analyses revealed the recombination events in the all three isolates studied. The study describes well the importance and novelty of the research in wild plants which act as reservoir hosts for viruses asymptomatically. Methodology section have been explained well to reproduce the experimental results. Results and discussion are well supported with the literature about recent studies related to potyviruses in wild plants. I would recommend the acceptance of manuscript for publication in its current form. Reviewer #3: This manuscript reports a possible recombinant isolate of LMoV. However, this document has multiple errors and lack of information. Among the main issues identified: The recombination analysis is based entirely on a small fragment of the viral genome (1689 bp), rather than the entire genome. The three identified LMoV isolates have >96% similarity to the same accession deposited in GenBank. The mechanical transmission experiment (bio-indexing) only demonstrated the infectivity of the virus in the inoculated plants, but no pathogenicity, no symptoms or damage were ever observed. It is well known that potiviruses, including LMoV, have a high degree of recombination, so what would be the originality of this analysis in this work? To say that Galanthus could be one of the natural hosts of LMoV and that this virus could also be native to Hungary, is very risky, and no information or data that could support such claims is presented. Finally, I suggest restructuring this work and presenting it as a first report of LMoV infecting Galanthus in Hungary. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Dr. Khadim Hussain Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Recombinant Potyvirus lilimaculae in asymptomatic Galanthus nivalis: Ecological and evolutionary implications PONE-D-25-31948R1 Dear Dr. László Palkovics, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cheorl-Ho Kim, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Dear Dr László Palkovics, Thank you for your appropriate revision of your original manuscript. I have rechecked the revision as you well did and found it acceptable for publication in Plos One. I would like to express my appreciation for your submission to Plos One. Thank you Sincerely Cheorl-Ho Kim Editor Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #4: Yes ********** Reviewer #1: The revised version of manuscript "Recombinant Potyvirus lilimaculae in asymptomatic Galanthus nivalis: Ecological and evolutionary implications" presents significant improvement compared to the first version. Most of the concerns of reviewers were suitably adressed by authors. I have some minor corrections/suggestions presented directly in the attached file. Reviewer #4: The revised manuscript has improved substantially in structure, clarity, and scientific presentation. Most previous concerns have been adequately addressed. The study provides novel and valuable data on Potyvirus lilimaculae (LMoV) in asymptomatic Galanthus nivalis, including molecular identification, phylogenetic analysis, recombination inference, and biological validation via sap inoculation. The integration of virology with conservation implications is particularly interesting and relevant. The manuscript is close to being acceptable. However, a few points require minor revision before final acceptance (refer to the attached file). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #4: Yes: Zaiton Sapak **********
|
| Formally Accepted |
|
PONE-D-25-31948R1 PLOS One Dear Dr. Palkovics, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Cheorl-Ho Kim Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .